Enhabit Swings to Profit, Boosted by Revenue Growth and No Goodwill Impairment

Ticker: EHAB · Form: 10-Q · Filed: Nov 5, 2025

Sentiment: bullish

Topics: Healthcare Services, Home Health, Hospice Care, Earnings Beat, Cash Flow Growth, Debt Reduction, Goodwill Impairment Reversal

Related Tickers: EHAB, EHC

TL;DR

**Enhabit's massive profit swing makes it a strong buy, as the goodwill impairment is behind them and cash flow is surging.**

AI Summary

Enhabit, Inc. reported a significant turnaround in its financial performance for the three and nine months ended September 30, 2025. Net service revenue increased to $263.6 million for the three months ended September 30, 2025, up from $253.6 million in the prior year, and to $789.6 million for the nine months, up from $776.6 million. The company achieved net income attributable to Enhabit, Inc. of $11.1 million ($0.22 per diluted share) for the three-month period, a substantial improvement from a net loss of $110.2 million ($2.20 per diluted share) in the same period of 2024. For the nine-month period, net income attributable to Enhabit, Inc. was $34.1 million ($0.67 per diluted share), compared to a net loss of $110.2 million ($2.20 per diluted share) in the prior year. This positive shift is largely due to the absence of the $107.9 million goodwill impairment charge recorded in the third quarter of 2024. Operating income rebounded to $16.8 million for the quarter and $49.4 million for the nine months, from operating losses of $98.0 million and $73.9 million, respectively, in 2024. Cash and cash equivalents significantly increased to $56.9 million as of September 30, 2025, from $28.4 million at December 31, 2024, driven by $66.3 million in net cash provided by operating activities for the nine months.

Why It Matters

This strong financial rebound for Enhabit, Inc. signals a potential stabilization and growth phase for the company, which is crucial for investor confidence after a challenging 2024 marked by significant losses. The improved profitability and cash flow could enable Enhabit to invest further in its home health and hospice services, potentially expanding its market share in a competitive healthcare landscape. For employees, a healthier financial position could mean greater job security and opportunities. Customers may benefit from enhanced service quality and accessibility as the company strengthens its operations. The competitive context shows Enhabit is navigating a complex reimbursement environment, with shifts in Medicare and Medicare Advantage revenue streams, indicating its ability to adapt and maintain service demand.

Risk Assessment

Risk Level: medium — While Enhabit, Inc. showed significant improvement, the company still operates in a highly regulated healthcare environment with inherent risks. The 'Cautionary Note Regarding Forward-Looking Statements' highlights risks such as changes in reimbursement rates, general economic conditions, and the ability to attract and retain healthcare professionals. The company's reliance on Medicare and Medicare Advantage, which collectively accounted for $176.4 million of its $263.6 million net service revenue in Q3 2025, exposes it to regulatory changes and payment methodology shifts.

Analyst Insight

Investors should consider Enhabit's improved profitability and strong operating cash flow as a positive indicator. Monitor future filings for sustained revenue growth, particularly in the Hospice segment which saw a significant increase to $63.1 million in Q3 2025 from $52.6 million in Q3 2024, and continued absence of impairment charges. Evaluate management's strategy for debt reduction, given the long-term debt of $441.5 million.

Financial Highlights

revenue
$263.6M
operating Margin
6.4%
total Debt
$441.5M
net Income
$11.1M
eps
$0.22
cash Position
$56.9M
revenue Growth
+3.9%

Revenue Breakdown

SegmentRevenueGrowth
Medicare$176.4M+4.4%
Hospice$63.1M+20.0%
Total Net Service Revenue$263.6M+3.9%

Key Numbers

Key Players & Entities

FAQ

What were Enhabit, Inc.'s net service revenues for the third quarter of 2025?

Enhabit, Inc. reported net service revenues of $263.6 million for the three months ended September 30, 2025, an increase from $253.6 million in the same period of 2024.

How did Enhabit, Inc.'s net income change from Q3 2024 to Q3 2025?

Enhabit, Inc. experienced a significant turnaround, reporting net income attributable to Enhabit, Inc. of $11.1 million in Q3 2025, compared to a net loss of $110.2 million in Q3 2024.

What was the primary reason for Enhabit, Inc.'s improved profitability in 2025?

The primary reason for Enhabit, Inc.'s improved profitability was the absence of the $107.9 million impairment of goodwill charge that was recorded in the three and nine months ended September 30, 2024.

What is Enhabit, Inc.'s current cash and cash equivalents position?

As of September 30, 2025, Enhabit, Inc. had cash and cash equivalents of $56.9 million, a substantial increase from $28.4 million at December 31, 2024.

How much cash did Enhabit, Inc. generate from operating activities in the first nine months of 2025?

For the nine months ended September 30, 2025, Enhabit, Inc. generated $66.3 million in net cash from operating activities, up from $55.3 million in the same period of 2024.

What are the key risks Enhabit, Inc. faces according to its 10-Q filing?

Key risks highlighted include changes in reimbursement rates, general economic conditions, the ability to attract and retain healthcare professionals, potential disruptions to information systems, and the outcome of litigation.

How has Enhabit, Inc.'s long-term debt changed?

Enhabit, Inc.'s long-term debt, net of current portion, decreased to $441.5 million as of September 30, 2025, from $492.6 million at December 31, 2024.

What is Enhabit, Inc.'s strategy regarding its two reportable segments?

Enhabit, Inc. manages its operations and discloses financial information using two reportable segments: Home Health and Hospice, indicating a focus on these distinct but related healthcare service areas.

What is the impact of the new FASB ASU 2024-03 on Enhabit, Inc.?

The FASB ASU 2024-03, effective for fiscal years beginning after December 15, 2026, requires more detailed expense disclosures. Enhabit, Inc. does not expect it to have a material impact on its consolidated financial statements, but it will require additional disclosures.

What was Enhabit, Inc.'s diluted earnings per share for the nine months ended September 30, 2025?

Enhabit, Inc. reported diluted earnings per share of $0.67 for the nine months ended September 30, 2025, a significant improvement from a diluted loss per share of $2.20 in the same period of 2024.

Risk Factors

Industry Context

Enhabit, Inc. operates in the home health and hospice care sector, a segment experiencing growth driven by an aging population and a preference for care in familiar settings. The industry is characterized by significant regulatory oversight and evolving reimbursement models, particularly from Medicare. Key competitors include other national home health providers and smaller regional agencies.

Regulatory Implications

The company is subject to stringent regulations from government agencies like CMS, impacting reimbursement rates and operational standards. Changes in healthcare policy, such as Medicare reimbursement adjustments or new quality reporting requirements, pose ongoing risks. Compliance with these regulations is critical to maintaining revenue streams and avoiding penalties.

What Investors Should Do

  1. Monitor reimbursement rate changes
  2. Assess labor cost management strategies
  3. Track growth in the hospice segment
  4. Evaluate debt reduction progress
  5. Analyze operational efficiency improvements

Key Dates

Glossary

Goodwill impairment
A reduction in the carrying value of goodwill on the balance sheet when its fair value is determined to be less than its carrying amount. This indicates that the acquired business is not performing as expected. (The absence of a $107.9 million goodwill impairment charge in Q3 2025 was the primary driver of the company's return to profitability compared to Q3 2024.)
Net service revenue
The total revenue generated from providing healthcare services, net of any contractual adjustments or allowances. (Reported at $263.6 million for Q3 2025, an increase from $253.6 million in the prior year, indicating top-line growth.)
Operating income (loss)
Profitability from a company's core business operations before accounting for interest, taxes, and other non-operating expenses. (Rebounded to $16.8 million in Q3 2025 from an operating loss of $98.0 million in Q3 2024, signaling improved operational efficiency.)
Diluted EPS
Earnings per share calculated after accounting for all dilutive potential common shares, such as stock options and convertible securities. (Improved to $0.22 in Q3 2025 from a loss of $2.20 in Q3 2024, reflecting enhanced profitability on a per-share basis.)
Cash and cash equivalents
Highly liquid investments that are readily convertible to cash, including currency on hand, bank deposits, and short-term government securities. (Increased significantly to $56.9 million as of September 30, 2025, from $28.4 million at December 31, 2024, indicating improved liquidity.)
Noncontrolling interests
The portion of equity interest in a subsidiary that is not attributable to the parent company. (Net income attributable to Enhabit, Inc. is reported after deducting net income attributable to noncontrolling interests, which was $0.5 million in Q3 2025.)
Depreciation and amortization
The systematic allocation of the cost of tangible assets (depreciation) and intangible assets (amortization) over their useful lives. (Decreased from $8.2 million in Q3 2024 to $5.5 million in Q3 2025, contributing to improved operating income.)
De novo locations
New business locations established from scratch, rather than acquired or through expansion of existing sites. (The company's ability to successfully integrate de novo locations is listed as a factor that could cause actual results to differ materially from forward-looking statements.)

Year-Over-Year Comparison

Enhabit, Inc. has demonstrated a significant financial recovery compared to the prior year's filing. Net service revenue for Q3 2025 increased by 3.9% to $263.6 million, and net income swung from a substantial loss of $110.2 million in Q3 2024 to a profit of $11.1 million in Q3 2025. This turnaround is primarily attributed to the absence of a $107.9 million goodwill impairment charge recorded last year, alongside improved operating income of $16.8 million. Cash and cash equivalents have more than doubled, reaching $56.9 million, driven by strong operating cash flows.

Filing Stats: 4,696 words · 19 min read · ~16 pages · Grade level 8 · Accepted 2025-11-05 16:24:42

Key Financial Figures

Filing Documents

Financial Statements (Unaudited)

Financial Statements (Unaudited) Condensed Consolidated Statements of Income 1 Condensed Consolidated Statements of Comprehensive Income 2 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Stockholders' Equity 4 Condensed Consolidated Statements of Cash Flows 6 Notes to Condensed Consolidated Financial Statements 7 Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 26 Item 4

Controls and Procedures

Controls and Procedures 26 Part II Other Information 27 Item 1

Legal Proceedings

Legal Proceedings 27 Item 1A

Risk Factors

Risk Factors 27 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 27 Item 5 Other Information 27 Item 6 Exhibits 28 Signature 29 i Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This quarterly report contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, the reader can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "targets," "potential," or "continue" or the negative of these terms or other comparable terminology. Any forward-looking statement speaks only as of the date of this report, and the Company undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties, many of which are beyond our control. Actual events or results may differ materially from the results anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by the Company include, but are not limited to, our ability to execute on our

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS (UNAUDITED)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED) ENHABIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) Three Months Ended September 30, Nine Months Ended September 30, (in millions, except per share data) 2025 2024 2025 2024 Net service revenue $ 263.6 $ 253.6 $ 789.6 $ 776.6 Cost of service, excluding depreciation and amortization 135.8 131.7 401.5 397.7 General and administrative expenses 105.5 103.8 321.2 321.3 Depreciation and amortization 5.5 8.2 17.5 23.6 Impairment of goodwill — 107.9 — 107.9 Operating income (loss) 16.8 ( 98.0 ) 49.4 ( 73.9 ) Interest expense and amortization of debt discounts and fees 8.3 10.8 26.4 32.8 Other (income) expenses 0.1 — ( 19.2 ) — Income (loss) before income taxes and noncontrolling interests 8.4 ( 108.8 ) 42.2 ( 106.7 ) (Benefit from) provision for income taxes ( 3.2 ) 0.7 6.5 1.5 Net income (loss) 11.6 ( 109.5 ) 35.7 ( 108.2 ) Less: Net income attributable to noncontrolling interests 0.5 0.7 1.6 2.0 Net income (loss) attributable to Enhabit, Inc. $ 11.1 $ ( 110.2 ) $ 34.1 $ ( 110.2 ) Weighted average common shares outstanding: Basic 50.7 50.2 50.8 50.2 Diluted 51.1 50.2 51.2 50.2 Earnings (loss) per common share: Basic earnings (loss) per share attributable to Enhabit, Inc. common stockholders $ 0.22 $ ( 2.20 ) $ 0.67 $ ( 2.20 ) Diluted earnings (loss) per share attributable to Enhabit, Inc. common stockholders $ 0.22 $ ( 2.20 ) $ 0.67 $ ( 2.20 ) The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 1 Table of Contents ENHABIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Three Months Ended September 30, Nine Months Ended September 30, (in millions) 2025 2024 2025 2024 Net income (loss) $ 11.6 $ ( 109.5 ) $ 35.7 $ ( 108.2 ) Other comprehensive income (loss): Unrealized gain (loss) on cash flow hedges, net of tax expense of $ — , $( 0.5 ), $ 0.1 , and $( 0.1 ) respectively — ( 1.8 ) 0.2 ( 0.4 )

View on Read The Filing